PepsiCo was hit with a consumer class action at the California Central District Court for putting the phrases 'healthy real hydration,' 'no added sugar' and 'excellent source of vitamins A & C' in the packaging of its Gatorade Fit drinks.
The suit, brought by Fitzgerald Joseph, alleges that phrases on the packaging are 'nutrient content claims', which is prohibited by FDA regulations.
A counsel has not yet appeared for PepsiCo.
PepsiCo introduced Gatorade Fit, an electrolyte drink in February last year.
According to Carolyn Braff, head of the brand strategy for Gatorade, Gatorade Fit’s ingredient profile clears the way to include the words “Healthy Real Hydration” prominently on the front label.
The FDA regulates the use of the word “healthy” on food labels.


Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
S&P 500 Rises as AI Stocks and Small Caps Rally on Strong Earnings Outlook
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
Trump Announces U.S.–India Trade Deal Cutting Tariffs, Boosting Markets and Energy Ties
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
Indian Rupee Strengthens Sharply After U.S.-India Trade Deal Announcement
Gold and Asian Stocks Rebound as Market Volatility Eases and Global Sentiment Improves
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Philippines Manufacturing PMI Hits Nine-Month High Despite Weak Confidence Outlook
China and Uruguay Strengthen Strategic Partnership Amid Shifting Global Order
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 



